Advances in nanoparticle-based doxorubicin delivery: precision strategies for targeted treatment of triple-negative breast cancer

Advances in nanoparticle-based doxorubicin delivery: precision strategies for targeted treatment of triple-negative breast cancer

Abstract Triple-negative breast cancer (TNBC) is a prevalent and aggressive subtype of breast cancer, accounting for approximately 10–15% of all cases. Its lack of hormone receptors and poor clinical prognosis make targeted therapy particularly challenging, leaving chemotherapy as the mainstay treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Navakanth Raju Ramayanam, Sarad Pawar Naik Bukke, Murali Krishna Moka, Himanshu Dehingia, Aditya Bordoloi, Riya Debbarma, Purushothama Reddy Kudumula, Balakrishna Vuyyala, P. Dharani Prasad, Akugizibwe Catherine
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Discover Nano
Subjects:
Triple-negative breast cancer (TNBC)
Doxorubicin (DOX)
Nanoparticle-based drug delivery
Precision medicine
Targeted & controlled drug delivery
Online Access:https://doi.org/10.1186/s11671-025-04308-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s11671-025-04308-5

Similar Items